Filter Results:
(1,739)
Show Results For
- All HBS Web
(1,739)
- People (5)
- News (461)
- Research (915)
- Events (8)
- Multimedia (12)
- Faculty Publications (469)
Show Results For
- All HBS Web
(1,739)
- People (5)
- News (461)
- Research (915)
- Events (8)
- Multimedia (12)
- Faculty Publications (469)
- December 2011
- Article
Data Impediments to Empirical Work on Health Insurance Markets
By: Leemore S. Dafny, David Dranove, Frank Limbrock and Fiona Scott Morton
We compare four datasets that researchers might use to study competition in the health insurance industry. We show that the two datasets most commonly used to estimate market concentration differ considerably from each other (both in levels and in changes over time),... View Details
Dafny, Leemore S., David Dranove, Frank Limbrock, and Fiona Scott Morton. "Data Impediments to Empirical Work on Health Insurance Markets." B.E. Journal of Economic Analysis & Policy 11, no. 2 (December 2011).
- 2015
- Working Paper
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
By: Pierre Azoulay, Joshua S. Graff Zivin, Danielle Li and Bhaven N. Sampat
We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly... View Details
Keywords: Economics Of Science; Patenting; Academic Reserach; NIH; Knowledge Spillovers; Patents; Research; Government and Politics
Azoulay, Pierre, Joshua S. Graff Zivin, Danielle Li, and Bhaven N. Sampat. "Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules." Harvard Business School Working Paper, No. 16-056, October 2015.
- 1984
- Article
Return to Nursing Home Investment: Issues for Public Policy
By: Carliss Y. Baldwin and Christine E. Bishop
Baldwin, Carliss Y., and Christine E. Bishop. "Return to Nursing Home Investment: Issues for Public Policy." Health Care Financing Review 5, no. 4 (1984).
- November 2013
- Case
GlaxoSmithKline in China (A)
By: John A. Quelch and Margaret L. Rodriguez
Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (A)." Harvard Business School Case 514-049, November 2013.
- 08 Mar 2017
- Op-Ed
Op-Ed: Can the Proposed American Health Care Act Improve on 'Obamacare'?
it passes in Congress. About the Authors John A. Quelch is the Charles Edward Wilson Professor of Business Administration at Harvard Business School. He also holds a joint appointment at Harvard T.H. Chan School of Public View Details
- October 2020
- Case
Michael Phelps: 'It's Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the greatest of all time—the highs and lows,... View Details
Keywords: Mental Health; Talent and Talent Management; Training; Health; Success; Performance Improvement; Personal Development and Career; Family and Family Relationships; Sports; Competition; Sports Industry; United States; Baltimore; Arizona; Sydney; Athens; Beijing; London
Groysberg, Boris, Carin-Isabel Knoop, and Michael Norris. "Michael Phelps: 'It's Okay to Not Be Okay'." Harvard Business School Case 421-044, October 2020.
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
- 2015
- Published Proceedings
Academic Engagement in Public and Political Discourse: Proceedings of the Michigan Meeting, May 2015
By: Andrew J. Hoffman, Kirsti Ashworth, Chase Dwelle, Peter Goldberg, Andrew Henderson, Louis Merlin, Yulia Muzyrya, Norma-Jean Simon, Veronica Taylor, Corinne Weisheit and Sarah Wilson
What is the role of the academic scholar within the discussions of the global challenges that are relevant to society, such as sustainability, health care, gun control, fiscal policy, and international affairs? How do scholars engage in a world in which knowledge is... View Details
Hoffman, Andrew J., Kirsti Ashworth, Chase Dwelle, Peter Goldberg, Andrew Henderson, Louis Merlin, Yulia Muzyrya, Norma-Jean Simon, Veronica Taylor, Corinne Weisheit, and Sarah Wilson, eds. Academic Engagement in Public and Political Discourse: Proceedings of the Michigan Meeting, May 2015. Michigan Publishing Services, 2015. Electronic.
- January 2009
- Case
When Supply is of Public Interest: Roche & Tamiflu
The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
- 12 Jul 2004
- Research & Ideas
Michael Porter’s Prescription For the High Cost of Health Care
We believe that competition is the root of the problem with U.S. health care performance. But this does not mean we advocate a state-controlled system or a single-payer system; those approaches would only make matters worse. On the... View Details
- Article
Applying KISS to Healthcare Information Technology
By: Regina E. Herzlinger, Margo Seltzer and Mark Gaynor
Current public and private healthcare information technology initiatives have failed to achieve secure integration among providers. Applying the "keep it simple, stupid" principle offers the key guidance for solving this problem. View Details
Keywords: Technology; Health Care; Public Health; Information Technology Industry; Computer Networks; Computer Services Industries; Software; Hardware; Medical Services; Health Care and Treatment; Information Technology; Applications and Software; Information Infrastructure; Standards; Health Industry; Health Industry; United States
Herzlinger, Regina E., Margo Seltzer, and Mark Gaynor. "Applying KISS to Healthcare Information Technology." Computer 46, no. 11 (November 2013): 72–74.
- 2014
- Other Unpublished Work
No Margin, No Mission? A Field Experiment on Incentives for Public Services Delivery
By: Nava Ashraf, Oriana Bandiera and Kelsey Jack
A substantial body of research investigates the effect of pay for performance in firms, yet less is known about the effect of non-financial rewards, especially in organizations that hire individuals to perform tasks with positive social spillovers. We conduct a field... View Details
Keywords: Incentives; Non-monetary Rewards; Intrinsic Motivation; Mission and Purpose; Social Enterprise; Motivation and Incentives
Ashraf, Nava, Oriana Bandiera, and Kelsey Jack. "No Margin, No Mission? A Field Experiment on Incentives for Public Services Delivery." (March 2014. Conditionally accepted, Journal of Public Economics.)
- Web
Value-Based Health Care - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care... View Details
- 18 Oct 2016
- Op-Ed
Why Business Should Invest in Community Health
those cases. No matter the approach, shareholders and the public are unlikely to recognize the full value of a firm’s community health programs and other health-related efforts if those activities are... View Details
- September–October 2022
- Article
Case Study: What's the Right Career Move After a Public Failure?
By: Jon M. Jachimowicz and Francesca Gino
“Reunions are for happy people,” Mariani Kallis said to her friend Whitney on the phone. “I’m not going.” “Come on, it won’t be the same without you,” Whitney pleaded. “Besides, no one is happy right now. Everyone’s life is a mess.”
“I’m pretty sure none of our... View Details
Jachimowicz, Jon M., and Francesca Gino. "Case Study: What's the Right Career Move After a Public Failure?" Harvard Business Review 100, no. 5 (September–October 2022): 144–149.
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
Professor of Public Policy at Harvard’s John F. Kennedy School of Government, conducted the research with Katherine Baicker of the University of Chicago and Mark Shepard, associate professor of public policy... View Details
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Africa; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- August 2003 (Revised September 2008)
- Background Note
Note on Financing of the U.S. Health Care Sector
By: Regina E. Herzlinger and Jeff Grahling
This course describes the public and private sources of financing of the U.S. health-care sector,and identifies the characteristics of insurance policies, their costs, the structure of the insurance industry, and the role of consultants and brokers. The insurance... View Details
Keywords: Economic Sectors; Financing and Loans; Insurance; Industry Structures; Health Industry; Health Industry; United States
Herzlinger, Regina E., and Jeff Grahling. "Note on Financing of the U.S. Health Care Sector." Harvard Business School Background Note 304-039, August 2003. (Revised September 2008.)
- 07 Aug 2009
- What Do You Think?
Why Can’t Americans Get Health Care Right?
centers, to some extent, on whether there should be a publicly administered alternative to the private health care system, as opposed to other countries in which private care is supplementary to the public... View Details
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
arrangements (HRA) rule and Joe Biden’s Public Option would go a long way to bringing more choice, affordability, and personal control to the purchase of health insurance. Trump’s rule enables employees in... View Details